Live Breaking News & Updates on Bio farma persero

Stay informed with the latest breaking news from Bio farma persero on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Bio farma persero and stay connected to the pulse of your community

Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon

JAKARTA, Indonesia, July 10, 2023 /PRNewswire/ -- Bio Farma, Indonesia's state-owned Pharmaceutical company, is collaborating with MIT Hacking Medicine to address urgent healthcare challenges in the region by holding the first-ever Bio Farma x MIT Hacking Medicine Hackathon. The 4-day event from August 24 to 27, 2023, in Bali, Indonesia, will have 200 participants consisting of students, startups, and health professionals from G20 countries and ASEAN member states. Jakarta (10/07) - Representatives from Bio Farma and MIT Hacking Medicine hold a media conference to answer the media's questions regarding the Bio Farma x MIT Hacking Medicine hackathon In conjunction, an online press conference will be held on July 11, 2023, at 8:30 AM (GMT+7) via Zoom. The press conference will offer an exclusive opportunity for media representatives to engage with key stakeholders, including Bio Farma executives, MIT representatives, and healthcare experts. The speakers of the press conference include: Soleh Udin Al Ayubi, Deputy Chief Executive Officer of Bio Farma, Tito Daniswara, Chief Operating Officer of SBU Bio Farma, Zahra Kanji, Director of MIT Hacking Medicine, and; Dilla Ibtida, Hub Manager of Innovation Factory. To register for the media press conference, please visit https://bit.ly/bioxmit-amasession. The healthcare markets in Southeast Asia encompass diverse variations across the region. However, there are four major challenges that will be addressed in 2023, which include the adoption of digital solutions, implementation of cost-effective and accessible healthcare, emphasis on home care and services, and the need for sustainable financing. "With the increasing complexities faced by the healthcare industry, it is paramount that we find solutions to preempt any problems before they grow too big to solve. By bringing in fresh perspectives that can be further refined by the leading experts in our industry, it is our hope that the hackathon will usher in a new era of medical excellence that will bring benefits to all," said Soleh Udin Al Ayubi, Deputy Chief Executive Officer of Bio Farma. Creating Comprehensive Solutions for End-to-End Healthcare Ecosystem The Bio Farma x MIT Hacking Medicine hackathon is open to the public, students, and professionals with technological and healthcare backgrounds within the Southeast Asia region. The event aims to create innovative solutions derived from the expertise of business strategists, designers, health Professionals, patients, entrepreneurs, and developers. Participants and their projects will be judged on the general health impact, innovation, business model, and overall presentation by the MIT team, Bio Farma, healthcare industry leaders, and seasoned professionals in the field. "We encourage participants to form teams that include individuals from diverse backgrounds, including gender, race, ethnicity, and socioeconomic status. This promotes a more inclusive environment and fosters collaboration among participants with different perspectives and experiences," added Zahra Kanji, Director of MIT Hacking Medicine. A Competitive Platform for Healthcare Innovation The top three winning teams will be rewarded prizes worth US$16,000 in total, including a trip to MIT Boston, sponsorship for the pilot implementation of their projects, additional funding, and even cloud vouchers. The Bio Farma X MIT Hacking Medicine hackathon is a dynamic and collaborative initiative that creates a highly competitive platform for innovative ideation. This program is designed to encourage conceptualization, formulation, and early-stage implementation of cutting-edge ideas that have the potential to revolutionize the healthcare industry. Throughout the competition, participants can count on the assistance of industry mentors and related workshops, as well as access pertinent data and information to help with their projects. Those interested in being part of history, can find out more information and join the Bio Farma x MIT Hacking Medicine hackathon at hackathon.biofarma.co.id. About Bio Farma PT Bio Farma (Persero) is the largest pharmaceutical holding company in Indonesia, which offer end-to-end services in the health industry, starting from pharmaceutical-related research and development, manufacturing, distribution to the operation of pharmacy, health clinics to clinical laboratories. Bio Farma's headquarter is sitting on a 91,058 square meter of land in Bandung, West Java, which comprises office buildings and factory facilities. The company also operates a representative office in Jakarta, Indonesia's capital city. Bio Farma is capable of producing more than 3.2 billion doses of vaccines per year. The company has exported its vaccine to more than 150 countries in the world. Bio Farma became a holding company after a merger of three listed state-owned pharmaceutical companies in Indonesia. The three companies PT Bio Farma (Persero), PT Kimia Farma Tbk (KAEF), PT Indofarma Tbk (INAF), merged into Bio Farma today. For further information, please visit www.biofarma.co.id. About MIT Hacking Medicine MIT Hacking Medicine is a non-profit organization part of Massachusetts Institute of Technology that empowers students, healthcare professionals, and entrepreneurs to solve healthcare challenges using technology and research-based design methodology. The company hosts hackathons, workshops, and other events in Boston and around the world to bring together people from different backgrounds to collaborate, innovate, and focus on relevant challenges to implement impactful healthcare solutions. Media Contact Feni Febriani Hastuti, Digital Marketing Officer of Bio Farma (feni.febriani@biofarma.co.id) Melati Hendaryani, Community Manager of Innovation Factory, BLOCK71 Bandung (mela@block71.co)

West-java , Jawa-barat , Indonesia , Boston , Massachusetts , United-states , Massachusetts-institute-of-technology , Bandung , Bali , Jawa-timur , Jakarta , Jakarta-raya

Indonesia provides 1.58 mln pentavalent vaccine doses to Nigeria

The Indonesian Agency for International Development (AID) has sent 1.58 million doses of the pentavalent vaccine produced by PT Bio Farma (Persero) for the ...

Antara , Aceh , Indonesia , Abuja , Abuja-federal-capital-territory , Nigeria , South-africa , Indonesian , Nigerian , Bio-farma-persero , Faisal-shuaibu , Usra-hendra-harahap

Bio Farma and the endeavor to build a healthcare ecosystem

The Indonesian government officially announced the revocation of its public activity restrictions (PPKM) policy on December 30, 2022.

The revocation ...

West-java , Jawa-barat , Indonesia , United-states , United-kingdom , Karawang , Indonesian , American , British , Profactor-pharma , Bio-farmahas , Bio-farma

Bio Farma diagnostic tool uses urine to detect cervical cancer

Bio Farma diagnostic tool uses urine to detect cervical cancer
indonesiatribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indonesiatribune.com Daily Mail and Mail on Sunday newspapers.

Antara , Aceh , Indonesia , Bio-farma , Honesti-basyir , Bio-farma-persero , Ministry-of-health ,

Bio Farma diagnostic tool uses urine to detect cervical cancer

State-run PT Bio Farma (Persero) has made a diagnostic tool that uses the latest technology to detect cervical cancer using urine samples, which, it claims, ...

Antara , Aceh , Indonesia , Bio-farma , Honesti-basyir , Bio-farma-persero , Ministry-of-health ,

Weekly investors roundup: New Super Down Under; BLF appoints new managers | Asset Owners

Vanguard launches a pension fund in Australia, the first new fund license to be approved in six years; Taiwan's Bureau of Labor Funds appoints seven asset managers - four foreign and three local; and more.

Australia , Taiwan , Japan , India , Hong-kong , Anbang , Zhejiang , China , Negara , Sumatera-utara , Indonesia , Singapore

Domestic vaccine IdoVac gets marketing permit

PT Bio Farma’s protein subunit platform COVID-19 vaccine, IdoVac, has obtained a marketing permit for use as a primary vaccine in the national ...

Airlangga , Jawa-timur , Indonesia , Tangerang , Jawa-barat , Bio-farma-indovac , Bio-farma , Lucia-rizka-andalusia , Honesti-basyir , Bio-farma-persero , Airlangga-university , Pt-biotis-pharmaceuticals-indonesia

IndoVac passes clinical trial for Covid booster: Bio Farma | Daily Express Online

The domestically produced IndoVac Covid-19 vaccine has passed the clinical trial for booster vaccination, the president director of state-owned pharmaceutical company PT Bio Farma Persero, Honesti Basyi said

Indonesia , Jakarta , Jakarta-raya , Indonesian , Indovac-covid , Antara-wuryanti-puspitasari , Honesti-basyi , Bio-farma , Honesti-basyir , Bio-farma-persero , Health-desk-media-gathering , Health-ministry

IndoVac passes clinical trial for COVID booster: Bio Farma

The domestically produced IndoVac COVID-19 vaccine has passed the clinical trial for booster vaccination, the president director of state-owned pharmaceutical ...

Indonesia , Antara , Aceh , Indonesian , Bio-farma , Honesti-basyir , Bio-farma-persero , Health-ministry , Drug-supervisory-agency , Farma-persero ,

Low-cost Haemophilia A treatment deal unlocks world of opportunity for ProFactor Pharma

Low-cost Haemophilia A treatment deal unlocks world of opportunity for ProFactor Pharma New agreement with Bio Farma opens estimated $1.36bn addressable Asian market A new patented process to make low-cost treatment for Haemophilia A, developed by Scottish biotechnology company ProFactor Pharma Ltd (PFP),...

Malaysia , Philippines , United-states , Thailand , India , United-kingdom , Singapore , Vietnam , Republic-of , Indonesia , America , Scotland